Log in
Enquire now
Inhibrx

Inhibrx

Inhibrx is an antibodies, Fusion Proteins founded by Mark P. Lappe, Brendan P. Eckelman and Quinn Deveraux.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
CEO
Mark P. Lappe
Mark P. Lappe
0
Legal Name
Inhibrx LLC
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz.../inhibrx
DUNS Number
040859583
Founder
Mark P. Lappe
Mark P. Lappe
0
‌
Quinn Deveraux
0
‌
Brendan P. Eckelman
0
Full Address
Torrey Pines Science Park 11025 N Torrey Pines Rd #200 La Jolla, CA 92037, USA
0
Industry
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Technology
Technology
Investors
City Hill Ventures
City Hill Ventures
Latest Funding Round Date
April 2020
LinkedIn URL
@company/inhibrx
Location
‌
La Jolla, Placentia, California
La Jolla
La Jolla
0
San Diego
San Diego
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
2
Phone Number
+18587954220
0
Exchange
Nasdaq
Nasdaq
Ticker Symbol
INBX
Total Funding Amount (USD)
70,000,000
Official Website
inhibrx.com

Find more companies like Inhibrx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.